|
Economic Analysis of Phase III Study of G-CSF Post alloPBSCT: Clinically Effective and Decreases Follow-Up Costs. |
| |
Allan Andresson Lima Pereira |
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Travel, Accommodations, Expenses - Amgen |
| |
|
Consulting or Advisory Role - Clinical Genomics |
Travel, Accommodations, Expenses - Array BioPharma |
| |
|
Consulting or Advisory Role - Bristol-Myers Squibb; Merrimack; Roche/Genentech |
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; MedImmune; Merck; Roche |
| |
Kanwal Pratap Singh Raghav |
Consulting or Advisory Role - Genentech (Inst) |
| |
|
Stock and Other Ownership Interests - Medtronic |
| |
|
Stock and Other Ownership Interests - GTx |
Consulting or Advisory Role - Incyte |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Bayer; Lilly; Roche |
Consulting or Advisory Role - Advaxis; Bayer Schering Pharma; Forty Seven; Roche/Genentech; Sirtex Medical; Taiho Pharmaceutical |
Research Funding - Advaxis; Genentech/Roche; Keryx |
Travel, Accommodations, Expenses - Bayer; Genentech/Roche |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Precision Medicine Research Associates, LLC |
Consulting or Advisory Role - Clovis Oncology; Precision Medicine Research Associates, LLC |
Patents, Royalties, Other Intellectual Property - Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition. |
| |
|
Employment - Guardant Health; Veracyte |
Leadership - Guardant Health |
Stock and Other Ownership Interests - Guardant Health; Veracyte |
Research Funding - Guardant Health |
| |
|
Employment - Guardant Health |
Leadership - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Research Funding - Guardant Health |
Patents, Royalties, Other Intellectual Property - Guardant Health |
Travel, Accommodations, Expenses - Guardant Health |
| |
|
Stock and Other Ownership Interests - Trovagene |
Consulting or Advisory Role - Deciphera; Foundation Medicine; Guardant Health; Novartis; Sequenom; Trovagene |
Research Funding - Agios; Astellas Pharma; Biocartis; BioMed Valley Discoveries; Deciphera; Foundation Medicine; Fujifilm; Novartis; Piqur; Plexxikon; Roche; Symphony Evolution; Trovagene |
Other Relationship - Bio-Rad |
| |
|
Stock and Other Ownership Interests - MolecularMatch; Navire |
Consulting or Advisory Role - Amgen; Array BioPharma; Bayer; EMD Serono; Genentech; Guardant Health (Inst); Karyopharm Therapeutics; Merck; Roche; Symphony Evolution |
Research Funding - Amgen (Inst); Array BioPharma (Inst); Biocartis (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Guardant Health (Inst); MedImmune (Inst); Novartis (Inst); Sanofi (Inst) |